Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA-A*31:01 and Oxcarbazepine-Induced DRESS in a Patient With Seizures and Complete DCX Deletion.

Pediatrics - 1 Apr 2018

Kim Hyun, Chadwick Laura, Alzaidi Yasir, Picker Jonathan, Poduri Annapurna, Manzi Shannon

Abstract excerpt

Oxcarbazepine is an antiepileptic drug (AED) commonly used as a first-line treatment option for focal epilepsy. Several AEDs, including carbamazepine, oxcarbazepine, and phenytoin are associated with various delayed-hypersensitivity reactions such as drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, or toxic epidermal necrolysis. The Food and Drug Administration-approved label for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticonvulsants
Share to Cross Reactions
Share to Doublecortin Domain Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Doublecortin Protein

Share to Epilepsies, Partial

Share to HLA-A Antigens

Share to Microtubule-Associated Proteins

Share to Neuropeptides

Source

Identifiers

PMID: 29610167
DOI: 10.1542/peds.2017-1361

Genes

DCX

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA-A*31:01 and Oxcarbazepine-Induced DRESS in a Patient With Seizures and Complete DCX Deletion.PMID 29610167Read ↗

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).Semantic proximity Read ↗

The risk of cutaneous adverse reactions among patients with the <i>HLA-A* 31:01</i> allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective reviewSemantic proximity Read ↗

Pharmacogenetics of antiepileptic drug-induced hypersensitivity.Semantic proximity Read ↗

HLA alleles and antiseizure medication-induced cutaneous reactions in Brazil: A case-control study.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 UpdateSemantic proximity Read ↗

Pharmacogenetics of cutaneous adverse drug reactionsSemantic proximity Read ↗

HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.Semantic proximity Read ↗

HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.Semantic proximity Read ↗

Association Between HLA genotypes and Oxcarbazepine-induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.Semantic proximity Read ↗

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art.Semantic proximity Read ↗

Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse ReactionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.